INXN-3002

N/A

Report date: 2023/10/26 17:03:48

Base Information

Drug NameINXN-3002
Drug Alias NameAutologous dermal fibroblasts genetically modified ex vivo with a lentiviral vector containing the human COL7A1 geneINXN-3002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesIntrexon Actobiotics Nv
China Registration ClassN/A

Develop Information

Active CompaniesIntrexon Actobiotics Nv
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A